1.A Novel Monoclonal Antibody With a Mono-specificity for a 46 ku-Cytokeratin
Jing FENG ; Yi SHEN ; Dongling YANG ; Xiyun YAN
Progress in Biochemistry and Biophysics 2006;33(1):24-30
A mAb T2-2 was generated using hybridoma techniques, and its target was identified as a 46 ku-cytokeratin (CK), based on biochemical study and a completely overlapped binding pattern of mAb T2-2 with anti-pan-CKs antibodies. An epithelia-specificity of the mAb T2-2 was determined by screening 68 human normal and 65 tumor tissues using immunohistochemistry. Unlike most of anti-CKs antibodies, the mAb T2-2 recognized a mono-specific epitope only expressed on the 46 ku CK, suggesting that mAb T2-2 is superior to most anti-CKs antibodies that cross-reacted with many different kinds of CKs. In addition, it was found that the mAb T2-2 was multipurpose with a broad applicability to ELISA, immunohistochemistry, immunofluorescence, Western blotting, and was also compatible with various fixation reagents. These results strongly indicate that the mAb T2-2 has potential applications for studying CKs function and for diagnosis of tumor and other disorders.
2.A Rapid Method for Distinguishing the DifferentGanoderma Lucidum Products by Fourier Transform Infrared Spectroscopy
Suqin SUN ; Deguo DU ; Xiyun LIANG ; Xianrong YANG
Chinese Journal of Analytical Chemistry 2001;29(3):309-312
A method of using Fourer transform infrared spectroscopy (FTIR) to detect 36 Ganoderma lucidun products rapidly and undamaged is reported. As the result, each of the samples has its characteristic infrared spectrum. By the difference of the relative intensity of those absorption peaks, different kinds of Ganoderma lucidums products can be detected. It is very fast, simple, reliable and has no solution effects.
3.Clinical Efficacy Observation of Zhishanghan Zhufeng Formula in Treatment of Knee Osteoarthritis
Xiyun YANG ; Jian GUO ; Yu WANG ; Zhiru CHEN
Chinese Journal of Information on Traditional Chinese Medicine 2015;22(11):28-30
Objective To observe the clinical efficacy of Zhishanghan Zhufeng Formula in treating knee osteoarthritis.Methods Totally 90 patients were randomly divided into treatment group and control group, 45 cases in each group. The treatment group was treated with Zhishanghan Zhufeng Formula for 30 days. The control group was treated with routine medicine (diclofenac sodium sustained release tablets and glucosamine sulfate tablets) for 30 days. The clinical efficacy and the changes of VAS, WOMAC score and knee temperature before and after treatment of two groups were observed.Results TCM clinical symptoms were significantly improved, and the effects in the treatment group were more evident compared with the control group (P<0.05). After treatment, VAS and WOMAC score of the two groups decreased obviously, while the knee temperature increased, and the treatment group was superior to the control group, with significant significance (P<0.05).Conclusion Zhishanghan Zhufeng Formula has effective clinical efficacy for knee osteoarthritis.
4.Clinical Research of Implantable Cardioverter Defibrillator
Zhongmei LIU ; Tao GUO ; Minghua HAN ; Ling ZHAO ; Shuming LI ; Xiyun YANG
Journal of Kunming Medical University 1989;0(01):-
Objective To report the clinical oberservation of 50 patients with implantable cardioverter defibrillator(ICD).Methods Observe the patients with ICD from May,1998 to Nov.2005.Results There were more than a thousand episodes of ventricular tachycardia ventricular fibrillation(VT/VF) detected and terminated by ICD devices.Conclusions ICD with tiered therapy function has high efficacy on the termination of ventricular tachyarrhythmias.It is important to follow up the patients and dynamically optimize the system of ICD.
5.Effects of Najia Method of Midday-midnight Point Selection for NSE and S100B Protein in Acute Ischemic Stroke Rats
Junfang SHANG ; Hua JIANG ; Xiyun YANG ; Wude ZHANG ; Jinhai WANG ; Zhidong LI ; Min ZHAO ; Yingcun BAO ; Chunhuan HUANG
Chinese Journal of Information on Traditional Chinese Medicine 2015;(6):54-57
Objective To observe the effects of Najia method of midday-midnight point selection for acute ischemic stroke (AIS) model rats onthe contents of NSE and S100B protein in serum. Methods SPF SD male rats were chosen to establish the models by middle cerebral artery bolt method. Rats were divided into blank group, sham-operation group, model group, channel-point group, and Najia method group by random number table method. Blank group, sham-operation group, and model group were in the absence of treatment, while the channel-point group received acupuncture treatment according to differentiation syndrome. Najia method group used Najia method of midday-midnight point selection to conduct acupuncture treatment once a day. Improvement of neural function and cerebral infarction volume were observed. The contents of NSE and S100B protein in serum were detected. Results Compared with model group, neurological function score, infarct volume and infarct volume percentage, and the contents of NSE and S100B protein in serum decreased in Najia method group and channel-point group (P<0.05, P<0.01). The effects of Najia group were generally better than the channel-point group. Conclusion Najia method of midday-midnight point selection can decrease the content of NSE and S100B protein in serum of AIS model rats, so as to achieve the effects of neuroprotection and treatment.
6.Study on the efficacy of CD34 + cells combined with sarpogrelate hydrochlotride tablets for the re-construction of the blood supply of thromboangiitis obliterans
Xue GAO ; Xiyun ZENG ; Yong YANG ; Guojian LI ; Guokai YANG
Journal of Chinese Physician 2017;19(12):1789-1791,1795
Objective To investigate the effect of autologous peripheral blood stem cell transplanta-tion combined with CD34 + cells and oral sarpogrelate hydrochloride for the treatment of vascular reconstruc-tion and blood supply on the thromboangiitis obliterans. Methods Thromboangiitis obliterans ( TAO) of 262 patients with 262 lower limbs were divided into stem cells CD34 + cells transplantation combined with sarpogrelate hydrochloride group ( group A) with 100 lower limbs, CD34 + stem cell transplantation group ( group B) with 91 lower limbs, and sarpogrelate hydrochloride oral group ( group C) with 71 lower limbs. The degree of lower limb local blood flow variability were calculated at the three levels of skin, blood vessels and blood by preoperative and postoperative use of multi-function monitoring instrument, Doppler detector, transcutaneous oxygen pressure monitor, and digital subtraction angiography ( DSA) , respectively. Results⑴ The degree of shank, foot cyanosis, cool skin, and pain was relieved significantly in groups A and B than in group C for 1 month after the treatment (P<0. 05). ⑵Intermittent claudication distance, the skin temperature of the lower leg and foot to patients in the groups A and B than in group C, with a significant difference (F=7. 01, F=7. 04, P<0. 05) for 3 months after the treatment. ⑶ Among the patients with amputation, 10 cases were in group A, 16 cases in group B, and 31 cases in group C for 6 months after the treatment. ⑷ Transcutaneous oxygen pressure was increased from ( 30. 43 ± 4. 31 ) mmHg to ( 37. 21 ± 9. 01)mmHg (F=5. 69, P<0. 05), ankle brachial index from (0. 32 ±0. 23) to (0. 91 ± 0. 16) (F=6. 71, P<0. 05), the volume of blood flow index from the photoelectric (0. 22 ± 0. 04) to (0. 83 ± 0. 13 (F=5. 69, P<0. 05), oxygen saturation from (42. 41 ±9. 61)% to (79. 61 ±20. 34)% (F=5. 74, P<0. 05), and DSA score (0. 23 ± 0. 03) increased to (1. 35 ± 0. 23) (F=7. 14, P<0. 05), which was sig-nificantly higher than group B and group C ( F=7. 01, F=7. 04, F=7. 12, F=7. 08, F=7. 15, P<0. 05) for one year after treatment. Conclusions Treatment of peripheral blood stem cells CD34 + cell transplantation combined with oral sarpogrelate hydrochloride can significantly improve the vascular regener-ation and its blood supply in TAO lower extremity limb.
7.Epstein-Barr virus induces human nasopharyngeal epithelial cells to escape from the replicative senescence.
Jing YANG ; Faqing TANG ; Huanhua GU ; Xiyun DENG ; Xinxian WENG ; Min TANG ; Ya CAO
Chinese Medical Journal 2002;115(6):803-809
OBJECTIVETo observe the biological changes of primary human nasopharyngeal epithelial cells in the early stage of immortalization.
METHODSThe morphological changes of nasopharyngeal epithelial cells were observed by phase contrast microscopy, and the activity profile of senescence-associated beta-galactosidase (SA-beta-Gal) was detected by SA-beta-Gal staining. The expression of p16(INK4a) protein was tested by immunochemical assay, and the life span in vitro of nasopharyngeal epithelial cells was calculated as population doublings. In addition, the expression of Epstein-Barr (EB) virus latent membrane protein 1 (LMP1) was also detected by immunofluorescence staining.
RESULTSMorphologically, cells treated with EB virus and 12-o-tetradecanoyl-phorbol-13-acetate (TPA) formed multi-layer foci, and their cellular life span in vitro was extended (about 155 days of culture). A low percentage of cells (about 4.8%) expressed SA-beta-Gal activity at late primary culture, and did not always express p16(INK4a) protein in the progression of culture.
CONCLUSIONSNasopharyngeal epithelial cells treated with EB virus in cooperation with TPA can pass through the stage of senescence and enter the early stage of immortalization. Some changes of phenotype occur in these cells. Our results provide data for further studying the mechanism of immortalization and the establishment of a human nasopharyngeal epithelial cell line.
Cell Transformation, Viral ; Cellular Senescence ; Cyclin-Dependent Kinase Inhibitor p16 ; analysis ; Epithelial Cells ; physiology ; virology ; Herpesvirus 4, Human ; physiology ; Humans ; Nasopharynx ; cytology ; virology ; Tetradecanoylphorbol Acetate ; pharmacology
8.FXYD6: a novel therapeutic target toward hepatocellular carcinoma.
Qian GAO ; Xiongfei CHEN ; Hongxia DUAN ; Zhaoqing WANG ; Jing FENG ; Dongling YANG ; Lina SONG ; Ningxin ZHOU ; Xiyun YAN
Protein & Cell 2014;5(7):532-543
FXYD6, FXYD domain containing ion transport regulator 6, has been reported to affect the activity of Na(+)/K(+)-ATPase and be associated with mental diseases. Here, we demonstrate that FXYD6 is up-regulated in hepatocellular carcinoma (HCC) and enhances the migration and proliferation of HCC cells. Up-regulation of FXYD6 not only positively correlates with the increase of Na(+)/K(+)-ATPase but also coordinates with the activation of its downstream Src-ERK signaling pathway. More importantly, blocking FXYD6 by its functional antibody significantly inhibits the growth potential of the xenografted HCC tumors in mice, indicating that FXYD6 represents a potential therapeutic target toward HCC. Altogether, our results establish a critical role of FXYD6 in HCC progression and suggest that the therapy targeting FXYD6 can benefit the clinical treatment toward HCC patients.
Animals
;
Antibodies, Monoclonal
;
pharmacology
;
Antineoplastic Agents
;
pharmacology
;
Carcinoma, Hepatocellular
;
drug therapy
;
metabolism
;
Cell Line, Tumor
;
Cell Movement
;
Cell Proliferation
;
Female
;
HEK293 Cells
;
Humans
;
Ion Channels
;
antagonists & inhibitors
;
metabolism
;
Liver Neoplasms
;
drug therapy
;
metabolism
;
Mice, Inbred BALB C
;
Mice, Nude
;
Sodium-Potassium-Exchanging ATPase
;
metabolism
;
Tumor Burden
;
drug effects
;
Xenograft Model Antitumor Assays
9.Impaired tumor angiogenesis and VEGF-induced pathway in endothelial CD146 knockout mice.
Qiqun ZENG ; Zhenzhen WU ; Hongxia DUAN ; Xuan JIANG ; Tao TU ; Di LU ; Yongting LUO ; Ping WANG ; Lina SONG ; Jing FENG ; Dongling YANG ; Xiyun YAN
Protein & Cell 2014;5(6):445-456
CD146 is a newly identified endothelial biomarker that has been implicated in angiogenesis. Though in vitro angiogenic function of CD146 has been extensively reported, in vivo evidence is still lacking. To address this issue, we generated endothelial-specific CD146 knockout (CD146(EC-KO)) mice using the Tg(Tek-cre) system. Surprisingly, these mice did not exhibit any apparent morphological defects in the development of normal retinal vasculature. To evaluate the role of CD146 in pathological angiogenesis, a xenograft tumor model was used. We found that both tumor volume and vascular density were significantly lower in CD146(EC-KO) mice when compared to WT littermates. Additionally, the ability for sprouting, migration and tube formation in response to VEGF treatment was impaired in endothelial cells (ECs) of CD146(EC-KO) mice. Mechanistic studies further confirmed that VEGF-induced VEGFR-2 phosphorylation and AKT/p38 MAPKs/NF-κB activation were inhibited in these CD146-null ECs, which might present the underlying cause for the observed inhibition of tumor angiogenesis in CD146(EC-KO) mice. These results suggest that CD146 plays a redundant role in physiological angiogenic processes, but becomes essential during pathological angiogenesis as observed in tumorigenesis.
Animals
;
CD146 Antigen
;
genetics
;
metabolism
;
Cells, Cultured
;
Endothelial Cells
;
cytology
;
metabolism
;
Female
;
Fibrosarcoma
;
metabolism
;
pathology
;
Male
;
Melanoma, Experimental
;
metabolism
;
pathology
;
Mice
;
Mice, Inbred C57BL
;
Mice, Knockout
;
NF-kappa B
;
metabolism
;
Neovascularization, Physiologic
;
drug effects
;
Phosphorylation
;
drug effects
;
Proto-Oncogene Proteins c-akt
;
metabolism
;
Retinal Vein
;
growth & development
;
pathology
;
Signal Transduction
;
drug effects
;
Transplantation, Homologous
;
Vascular Endothelial Growth Factor A
;
pharmacology
;
Vascular Endothelial Growth Factor Receptor-2
;
metabolism